Lobbying

American Association of Colleges of Osteopathic Medicine's latest lobbying report covers Q2 2026, at $230K. The four quarters Q4 2025–Q3 2026 total $620K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

American Association of Colleges of Osteopathic Medicine

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$620K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

American Association of Colleges of Osteopathic Medicine lobbying by quarter
American Association of Colleges of Osteopathic Medicine lobbying by quarter
QuarterAmountReports
Q4 2022$100K2
Q1 2023$100K2
Q2 2023$120K2
Q3 2023$100K2
Q4 2023$140K2
Q1 2024$180K3
Q2 2024$230K3
Q3 2024$230K3
Q4 2024$180K3
Q1 2025$220K3
Q2 2025$220K3
Q3 2025$250K3
Q4 2025$190K3
Q1 2026$200K3
Q2 2026$230K3
Q3 2026$00

By issue

  • Health issues$1.4M · 40 reports
  • Budget and appropriations$351K · 15 reports
  • Education$351K · 15 reports
  • Veterans$351K · 15 reports
  • Defense$226K · 11 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES40 reports
  • SENATE40 reports
  • Health & Human Services, Dept of (HHS)20 reports
  • Natl Institutes of Health (NIH)20 reports
  • Education, Dept of15 reports
  • Health Resources & Services Administration (HRSA)15 reports
  • Veterans Affairs, Dept of (VA)15 reports
  • Defense, Dept of (DOD)14 reports
  • Centers For Medicare and Medicaid Services (CMS)9 reports
  • Agency for Healthcare Research & Quality (AHRQ)8 reports
  • Indian Health Service8 reports
  • Centers For Disease Control & Prevention (CDC)7 reports
  • Office of Management & Budget (OMB)5 reports
  • Medicare Payment Advisory Commission (MedPAC)2 reports
  • Homeland Security, Dept of (DHS)1 reports
  • Labor, Dept of (DOL)1 reports

Firms it paid

Firm
In-houseAmerican Association of Colleges of Osteopathic Medicine$1.6M15 quarters
Venable$670K15 quarters
Crossroads Strategies$390K10 quarters

Former officials lobbying for it

Former position
JACKSON KENDRIC STUTEVILLELegislative Intern, Rep. Kendra HornQ4 2025
LILA OSMANPaid Intern, Sen. Roger WickerQ3 2025
STEPHEN THOMAS VOLJAVECLegislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha BlackburnQ2 2025
LUCIA PANZACounsel, U.S. Senator Charles E. Schumer; Counsel, U.S. Senate Judiciary Committee; Legislative Assistant, U.S. Senator Barbara Boxer; Law Clerk, Senate Health, Education, Labor & Pensions Committee; Law Clerk, Senate Judiciary CommitteeQ2 2024
BRYAN KERN WILLIAMSSpecial Assistant, Legislative Correspondent, Legislative Aide: Sen. Doug JonesQ1 2024
MARC NUMEDAHLLegislative Director, Rep. Dave Loebsack; Military Legislative Assistant, Rep. Rick LarsenQ1 2024
RICHARD JOSEPH WARD iiiCommunications Advisor, Senator Mitch McConnell; Senior Press Advance Representative, White House Office of Presidential Advance, Travel Manager, White House Travel Office; Special Assistant, Staff Assistant, White House Management OfficeQ1 2024
SALIM ALAMEDDINLegislative Asst/Legislative Aide, Rep. Will Hurd; Legislative Correspondent/Staff Asst, Sen. John CornynQ1 2024
STEPHANIE LEGERDeputy Projects Director, Sen. Mary Landrieu; Counsel, Sen. John BreauxQ1 2024
DAVID MULLONSenate Committee on Indian Affairs, Staff Director and Chief Counsel, General Counsel, Deputy Chief Counsel, Senior CounselQ1 2023

Lobbying reports

Filed by
09/29for Q4 2025In-house$100K
07/20for Q2In-house$140K
07/18for Q2Crossroads Strategies$40K
07/16for Q2Venable$50K
04/20for Q1In-house$110K
04/20for Q1Crossroads Strategies$40K
04/19for Q4 2025Crossroads Strategies$40K
04/13for Q1Venable$50K
01/19for Q4 2025Crossroads Strategies$40K
01/16for Q4 2025In-house$100K
01/13for Q4 2025Venable$50K
25/10/19for Q3 2025Crossroads Strategies$40K
25/10/17for Q3 2025In-house$160K
25/10/17for Q3 2025Venable$50K
25/07/30for Q2 2025Venable$50K
25/07/30for Q1 2025Venable$50K
25/07/30for Q4 2024Venable$50K
25/07/19for Q2 2025Crossroads Strategies$40K
25/07/18for Q2 2025In-house$130K
25/07/15for Q2 2025Venable$50K